Expired Canadian patentCanada
Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase
CA 2034612 C · Owner: Aventis Pharma Inc. · Inventors: Jarvi, Esa T.; Mccarthy, James R.; Edwards, Michael L.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to certain novel di- and tetra-fluoro analogs of squalene and to their methods of use in lowering plasma cholesterol and in inhibiting squalene epoxidase in patients in need thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 21, 1991 and granted May 15, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 21, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 21, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 21, 1991
GrantedMay 15, 2001
Term endedJanuary 21, 2011
Patent numberCA 2034612 C
Classification (IPC)C07C21/21 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.